By Tatum Anderson for Intellectual Property Watch One of the most vocal voices for the interests of cancer patients in India says it will use the courts to force the Indian government to declare cancer a national emergency, in an attempt to make cancer drugs affordable to sufferers. The Cancer Patients Aid Association (CPAA) wants [...]
No Comments »
Filed under: Campaign, News
Even with the rejection of the appeal by from Novartis AG by the High Court in Madras on the ground that it was only an incremental innovation, the pharmaceutical companies appear to be aggressively pursuingand securingpatents for drugs that would fall under Indias frivolous patenting guidelines that bar such incremental innovations from getting patent protection.The [...]
No Comments »
Filed under: Campaign
Times Of India
No Comments »
Filed under: Campaign, News
By Keya Acharya , IPS news BANGALORE, Aug 27 (IPS) – Activist groups campaigning for affordable drugs will continue their boycott campaign against Swiss pharma major Novartis AG, whose controversial petition arguing that Indian patent laws violated World Trade Organisation (WTO) provisions was rejected by the Madras High Court in southern Chennai city. The reason [...]
No Comments »
Filed under: Campaign, News
The case filed by the big pharmaceutical company Novartis has attracted global attention. “Doctors Without Borders” winner of the Nobel Prize for best medical relief in 1999, has requested people all over the world to write to the company to drop the case. Over two lakh people have written to Novartis. Why is this case [...]
No Comments »
Filed under: Article, Campaign
In 1997, Novartis AG filed a patent application in the Chennai ( Madras) Patent Controller’s office for the beta-crystalline of Imatinib Mesylate, brand name Glivec (Gleevec) on the ground that they invented the beta crystalline salt form (imatinib mesylate) of the free base, imatinib. In 2003, it was granted Exclusive Marketing Rights (EMR) for marketing [...]
No Comments »
Filed under: Article, Campaign, News
Medical Patent News , March 8, 2007 A court in Chennai, India, last month heard arguments in the case regarding Novartis claims to Gleevec Patents in India. Some HIV/AIDS advocacy groups are calling on Novartis to drop its legal challenge, saying that if the company wins the case it could restrict access to antiretroviral drugs [...]
No Comments »
Filed under: Campaign, News
Novartisboycott tagged on Del.icio.us